Home : Unsafe Drugs : Cimzia : News Articles

Cimzia - News Articles

OfficialWire: Company Financials: Nektar Therapeutics - New Report Published: OfficialWire (press release)
including UCB's Cimzia for rheumatoid arthritis and Crohn's Disease, Roche's PEGASYS for hepatitis C and Amgen's Neulasta for neutropenia. ...
UCB : Interim Report - Cimzia?, Vimpat? and Neupro? build momentum: Zenopa
These impacts should be partially offset by the growth of the newly launched products Cimzia(®), Vimpat(®) and Neupro(®). million. ...
New Efficacy Data Shows Cimzia(R) (certolizumab pegol) Provides Long-Term Remission of Moderate to Severe Crohn's Disease... -- ATLANTA, May 2 /PRNewswire/ --: Cimzia is indicated for reducing the signs and symptoms of Crohn's Disease and maintaining clinical response in adult patients with moderately to severely active rheumatoid arthritis. Certolizumab pegol was approved in Switzerland for induction of a clinical response and for ...
Osiris Resumes Enrollment in Stem Cell Trial for Crohn's Disease Following Positive Interim Analysis - MarketWatch: Bradenton Herald
Remicade(R) is a registered trademark of Centocor, Inc., Cimzia(R) is a registered trademark of the UCB Group of Companies, and Humira(R) is a registered ...
Watch List: XOMA Limited (NASDAQ:XOMA) | Penny Stock Live: Some of its excellent products include; LUCENTIS(R) for macular degeneration and CIMZIA(R) for rheumatoid arthritis and Crohn's disease and are producers of remedies for many other inflammatory antibodies for osteoarthritis and diabetes. They possess wide intellectual property and recently ...
XOMA to Announce 2010 First Quarter Financial Results and Host Webcast Conference Call on May 6 - MarketWatch: including LUCENTIS(r) (ranibizumab injection) for wet age-related macular degeneration and CIMZIA(r) (certolizumab pegol) for rheumatoid arthritis and Crohn's disease. ...
Biologicals Continue to Change the Therapeutic Picture for Autoimmunity | USPRwire: Humira, Simponi, and Cimzia become the cornerstone of treatment for a growing number of patients with advanced forms of autoimmunity. In spite of recent progress, a number of autoimmune diseases continue to represent an area ...
New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010: Studies and analyses of the Crohn's Disease (CD) treatment Cimzia® (certolizumab pegol) demonstrating new data will be exhibited at Digestive Disease Week (DDW) 2010, taking place in New Orleans from May 1-5, 2010. “Cimzia ...
: [10] W 2009 roku opublikowano takze wyniki badan, w których u chorych na RZS stosowano inne leki biologiczne: certolizumab pegol[11] i golimumab[12]; ...
Overvåkingslisten er oppdatert - RELIS - Produsentuavhengig legemiddelinformasjon: I gruppen Biologiske inflammasjonsdempende og immunsupprimerende legemidler, inkluderes nå de nye legemidlene Cimzia (certolizumab pegol), Ilaris (canakinumab), RoActemra (tocilizumab), Simponi (golimumab) og Stelara (ustekinumab). Legemiddelverket er interessert i kardiovaskulære bivirkninger av Cimzia, RoActemra og ...

Exagen Debuts Molecular Test to Distinguish IBD Subtypes; Eyes Companion Dx Use | The Sample | GenomeWeb: Monoclonals on the market today include Remicade (infliximab), sold by Centocor Ortho Biotech; Humira (adalimumab), marketed by Abbott; Cimzia (certolizumab pegol), sold by UCB; and Tsyrabi (Natalizumab), co-marketed by Biogen Idec and Élan. Cormier said Exagen "has ...
MME Hires Crystal Zheng as Digital Media Planner | webnewswire.com: Prior to MME, Zheng worked at Heartbeat Digital, NY, on UCB's Cimzia brand. She started her digital media career at Rockett Interactive, NC, where she worked in numerous categories (Banking, Healthcare / Hospitals, B2B, Entertainment, Education and Packaged Goods). Ms. Zheng is ...
FastMoneyTalk.com: Smokefree Innotec, Inc. & XOMA Ltd. Group Profiled by FastMoneyTalk.com | TradingMarkets.com: including LUCENTIS(r) (ranibizumab injection) for wet age-related macular degeneration and CIMZIA(r) (certolizumab pegol) for rheumatoid arthritis and Crohn's disease. The company has a premier antibody discovery and development platform that incorporates an unmatched collection ...
=> JPMorgan hebt Ziel f?r UCB auf 32 Euro - 'Underweight': Cimzia, ein Mittel gegen Morbus Crohn und rheumatische Arthritis, bleibe der Hauptwachstumstreiber, dürfte aufgrund der geringen Unterschiede zu herkömmlichen Präparaten nicht den zuvor erwarteten Spitzenumsatz erreichen, schrieb Analyst Richard Vosser in einer Studie vom Montag. Gleichzeitig habe ...
UCB Pharma - Cimzia subventioneras och finns nu tillgänglig i Sverige - MyNewsdesk: Cimzia (certolizumab pegol) – den enda TNF-hämmare som består av ett pegylerat Fab-fragment av en antikropp – finns nu tillgänglig i Sverige. Cimzia ges med en förfylld spruta som är specialdesignad i samarbete med OXO Good Grips® . Cimzia är ...
??????????????????????????? - ????????? -?????: ????????????????????,??TNFa???????,??etanercept?adalimumab?remicdae?abatacept?certolizumab pegol?golimumab?? ...
??????????????????? ?????????????? -???????|?????-?????: ????????????????????,??TNFa???????,??etanercept?adalimumab?remicdae?abatacept?certolizumab pegol?golimumab?? ...
UCB BE0003739530 UCB : UCB déclassé d'acheter à neutre par Nomura, Recos analystes - Investir.fr: BT) d'acheter à neutre, car elle juge que ses prévisions de ventes pour ses trois médicaments phares - Cimzia, Vimpat et Neupro - ont un faible potentiel de révision en hausse. La banque note que les projections à long terme du groupe pour les ventes de ces ...
PR-CANADA.net - Orencia Early Leader Among New Biologics to Treat Rheumatoid Arthritis: However, new biologics Simponi and Cimzia are finding important niche cases that could impact future prescribing. "Our data shows that Orencia has established itself as the early leader due to its safety profile and special patient populations, such as those with ...
Arzneimittelspritze gegen Rheumatoide Arthritis gewinnt Designpreis auf CeBIT - Design bei Rheumatoider Arthritis: Zusatznutzen für Patienten | Medizin - Pressemeldungen: Bei der Gestaltung der Spritze und Verpackung von Certolizumab Pegol vertraute UCB auf die Expertise von OXO® und Smart Design. Das Unternehmen OXO® hat sich auf sogenanntes Universal Design von Dingen des täglichen Gebrauchs spezialisiert. Hinter dem Begriff steht das Prinzip, Produkte so ...

Want to contact a District of Columbia Cimzia lawyer? ...Get a free case evaluation from one of our District of Columbia Cimzia lawyers now.

Pages: Previous 1 2 3 4 5 6 7 Next

Need A Cimzia Attorney?

First Name Last Name Email Address State

Legal Issue

Unsafe Drugs: Cimzia Click to select a Legal Issue

Was Your Health Negatively Affected?

Please Describe the Injury

close this window

Cimzia Information

Click to View Our Legal Resources

Want to contact a District of Columbia Cimzia lawyer? ...Get a free case evaluation from one of our District of Columbia Cimzia lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-020501

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

Unsafe Drugs: Cimzia Click to select a Legal Issue

Close (x)

Find Legal Help for Your Cimzia Case - Submit Your Information Below

Do you need legal assistance with your Cimzia case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * Unsafe Drugs: Cimzia Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.